Abilify oral solution
Otsuka Pharmaceuticals (UK) Ltd
ABILIFY 1 mg/ml oral solution
Each ml contains 1 mg of aripiprazole.
200 mg fructose per ml
400 mg sucrose per ml
1.8 mg methyl parahydroxybenzoate (E218) per ml
0.2 mg propyl parahydroxybenzoate (E216) per ml
For the full list of excipients, see section 6.1.
Oral solution
Clear, colourless to light yellow liquid.
ABILIFY is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.
ABILIFY is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in adults who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment (see section 5.1).
ABILIFY is
